Streetbeat News

Analyst Ratings

KPTI

Traders are closely monitoring Karyopharm Therapeutics (KPTI) following analyst comments suggesting potential acquisition interest from larger cancer companies for its drug Selinexor, in light of the MOR takeover interest.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:23 pm

TSLA

Piper Sandler analyst Alexander Potter maintained an Overweight rating on Tesla, Inc. (NASDAQ:TSLA) but reduced the price target from $295 to $225, citing a lowered 2024 volume estimate from 2.18 million units to 1.93 million units. The reduction is attributed to Tesla's aging product lineup and the prioritization of the Cybertruck over a cheaper, more broadly appealing vehicle. Despite near-term skepticism, Potter remains bullish on Tesla's long-term prospects, highlighting the potential in non-automotive segments like Tesla Energy.

Portfolio Pulse from Shanthi Rexaline

February 05, 2024 | 5:22 pm

JKS

Daiwa Capital analyst Dennis Ip downgraded JinkoSolar Holding Co (NYSE:JKS) from Outperform to Neutral and set a price target of $25. This adjustment reflects a change in the firm's outlook on JinkoSolar's stock.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:19 pm

SINT

Maxim Group analyst Tate Sullivan downgrades SINTX Techs (NASDAQ:SINT) from Buy to Hold.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:17 pm

CFLT

UBS analyst Karl Keirstead has maintained a Neutral rating on Confluent (NASDAQ:CFLT) and raised the price target from $21 to $26.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:14 pm

CB

UBS analyst Brian Meredith has maintained a Neutral rating on Chubb (NYSE:CB) and increased the price target from $245 to $256.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:08 pm

CAH

UBS analyst Kevin Caliendo maintains a Buy rating on Cardinal Health (NYSE:CAH) and raises the price target from $122 to $125.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:07 pm

BKNG

UBS analyst Lloyd Walmsley has maintained a Buy rating on Booking Holdings (NASDAQ:BKNG) and increased the price target from $4000 to $4200.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:05 pm

AXS

UBS analyst Brian Meredith has maintained a Buy rating on Axis Capital Holdings (NYSE:AXS) and increased the price target from $77 to $80.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:02 pm

ABNB

UBS analyst Lloyd Walmsley maintains a Neutral rating on Airbnb (NASDAQ:ABNB) and raises the price target from $125 to $148.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:01 pm